ADAGE CAPITAL PARTNERS GP, L.L.C.
Position in CMPX — Compass Therapeutics, Inc.
CIK 1165408
Boston, MA
Position in CMPX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,598,435
-$42,295,150 QoQ
Shares Held
1,186,500
-86.0% QoQ
Ownership
0.659%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 213 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CMPX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. CMPX ranks #107 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in CMPX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,598,435 | 1,186,500 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $44,893,585 | 8,486,500 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $23,824,005 | 4,436,500 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $18,152,750 | 5,186,500 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,504,656 | 4,424,868 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,552,500 | 3,975,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,692,474 | 5,994,810 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $20,479,200 | 11,130,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,130,000 | 11,130,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $22,037,400 | 11,130,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $15,412,800 | 9,880,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $12,568,600 | 6,380,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $19,875,000 | 6,250,000 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $20,437,500 | 6,250,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $29,047,244 | 5,774,800 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,503,048 | 4,606,600 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,677,490 | 4,406,600 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,119,490 | 2,277,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,438,000 | 1,400,000 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||